A PHYLOGENETIC APPROACH TO EVALUATE THE RELATION BETWEEN miRNA EXPRESSIONS AND HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA

Objective: Hepatitis C virus(HCV) infection increases the risk for Hepatocellular carcinoma (HCC) development, which is the sixth most common cancer type worldwide. HCV-related HCC has high mortality rates and HCV genotype is shown to affect survival in HCC. Two molecules that are known to be associated with poor cancer prognosis in HCC are endoplasmic reticulum transmembrane stromal interaction molecule 1(STIM1) and plasma membrane calcium channel(Orai1). Materials and Methods: In this study, we have enhanced STIM1 and/or Orai1 expressions in subpopulation of cancer-stem-cell-like cells in Huh7 HCC cell line in order to mimic poor cancer prognosis and performed next generation sequencing on small RNA samples isolated from these cells in order to identify the changes in miRNA expression patterns. Multiple alignment and phylogenetic analysis were used on stem loop sequences of miRNAs with significant expression changes and tried to identify a possible evolutionary relation of these miRNAs with HCV genotypes. Results: Our results showed that there were 5 different regions in HCV genome where these miRNAs are mostly aligned. miR4521, miR3651, miR7974 and miR6715a showed closed relations with HCV-genotypes-1 and -7 within these regions. These miRNAs also known to be related with cancer progression in several cancer types including HCC. Conclusion: We propose that a phylogenetic approach can be helpful to evaluate the evolutionary strategies of cancer promoting viruses as well as possible viral origins of miRNAs that play role in cancer progression.

A PHYLOGENETIC APPROACH TO EVALUATE THE RELATION BETWEEN miRNA EXPRESSIONS AND HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA

Objective: Hepatitis C virus(HCV) infection increases the risk for Hepatocellular carcinoma (HCC) development, which is the sixth most common cancer type worldwide. HCV-related HCC has high mortality rates and HCV genotype is shown to affect survival in HCC. Two molecules that are known to be associated with poor cancer prognosis in HCC are endoplasmic reticulum transmembrane stromal interaction molecule 1(STIM1) and plasma membrane calcium channel(Orai1). Materials and Methods: In this study, we have enhanced STIM1 and/or Orai1 expressions in subpopulation of cancer-stem-cell-like cells in Huh7 HCC cell line in order to mimic poor cancer prognosis and performed next generation sequencing on small RNA samples isolated from these cells in order to identify the changes in miRNA expression patterns. Multiple alignment and phylogenetic analysis were used on stem loop sequences of miRNAs with significant expression changes and tried to identify a possible evolutionary relation of these miRNAs with HCV genotypes. Results: Our results showed that there were 5 different regions in HCV genome where these miRNAs are mostly aligned. miR4521, miR3651, miR7974 and miR6715a showed closed relations with HCV-genotypes-1 and -7 within these regions. These miRNAs also known to be related with cancer progression in several cancer types including HCC. Conclusion: We propose that a phylogenetic approach can be helpful to evaluate the evolutionary strategies of cancer promoting viruses as well as possible viral origins of miRNAs that play role in cancer progression.

___

  • Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109(15):276-81.
Sağlık Bilimlerinde İleri Araştırmalar Dergisi-Cover
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2018
  • Yayıncı: İstanbul Üniversitesi
Sayıdaki Diğer Makaleler

DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER

Milad ASADİ, Dariush SHANEHBANDİ, Ayse CANER, Habin ZARREDAR, Shahram GASEMBAGLOU, Venus ZAFARİ, Tuoraj ASVADİ KERMANİ, Ayşe CANER

INVESTIGATION OF CIRCULAR RNAs AS BIOMARKERS IN HEAD AND NECK CANCER CELLS AND THE EFFECTS OF RADIOTHERAPY ON CIRCULAR RNAs

Can MUFTUOGLU, Ufuk MERT, Emin TAVLAYAN, Milad ASADİ, Özlem ÖZKAYA AKAGÜNDÜZ, Ayşe CANER

IMPACT OF COMPREHENSIVE GENOMIC PROFILING NGS PANELS IN PRECISION ONCOLOGY: THE CITY OF HOPE CMDL EXPERIENCE

Milhan TELATAR

EFFECT OF THYMOQUINONE IN COMBINATION WITH NIVOLUMAB ON EXPERIMENTAL RENAL CELL CANCER MODELS

Ahmet DİRİCAN, Safiye AKTAŞ, Tekincan Çağrı AKTAŞ, Aylin EROL, Özde Elif GÖKBAYRAK, Efsun KOLATAN, Efe Özgür SERİNAN, Zekiye ALTUN, Işıl SOMALI, Osman YILMAZ

EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPY

Saina RAHİMİ, Milad ASADİ, Can MUFTUOGLU, Emin TAVLAYAN, Ozlem OZKAYA AKAGUNDUZ, Ufuk MERT, Ayse CANER

A PHYLOGENETIC APPROACH TO EVALUATE THE RELATION BETWEEN miRNA EXPRESSIONS AND HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA

Ayşe Banu DEMİR

INVESTIGATION OF METHYLATION AND EXPRESSION STATUS OF PAX1 GENE VIA EPIGENOMIC PROFILING IN ORAL MALIGNANT LESIONS

Arda OZTAN, Gülsüm AK, Murat ULUSAN, Semra DEMOKAN

REPURPOSING DRUGS FOR CANCER THERAPY

Ege ARZUK, Ali ERGÜÇ, Fuat KARAKUŞ

NOVEL EPIGENETIC BIOMARKER DETERMINATION FOR OSCC BY ARRAY-BASED EPIGENOMIC AND TRANSCRIPTOMIC TECHNIQUES

Semra DEMOKAN, Sena SEN, Onder ERYILMAZ, Sevde COMERT, Murat ULUSAN, Mehmet Nejat DALAY

NEXT-GENERATION SEQUENCING IN CANCER: GENETIC DIAGNOSIS, RISK PREDICTION AND CLASSIFICATION

Ozkan OZDEMİR